# FDA recall Z-1399-2024

> **Becton Dickinson & Co.** · Class II · device recall initiated 2024-02-29.

## Product

BD Phoenix Yeast ID Panel is a self-inoculating (when used with a BD Phoenix Automated Microbiology System) polystyrene panel (tray) containing control wells and substrate wells with dried biochemical substrates that use traditional qualitative microbiology methods such as fermentation, oxidation, degradation, and hydrolysis in combination with chromogenic and fluorogenic substrates along with carbon sources for yeast identification.

## Reason for recall

Esculin, a substrate used in other panels and  normally in A16 well, was found in A17 well. A17 in yeast panels is supposed to be an  empty well and is not a part of the normal ID evaluation. However, A17 is checked for  fluorescence and if anything is found, the system will abort the panel with the message  Fluorescent interference has been detected. Esculin is expected to trigger this  fluorescence and test cancellation.

## Distribution

Worldwide distribution - US Nationwide and the countries of AR, BE, CO, IN, JP, PE, PY, SG,  TW, UY.

## Key facts

- **Recall number:** Z-1399-2024
- **Recalling firm:** Becton Dickinson & Co.
- **Classification:** Class II
- **Product type:** device
- **Status:** Ongoing
- **Initiation date:** 2024-02-29
- **Report date:** 2024-04-10

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Sparks, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1399-2024

## Citation

> AI Analytics. FDA recall Z-1399-2024. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/Z-1399-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*